Clinical Trial Update: Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial evaluating hypo-fractionated proton radiation therapy for low-risk prostate cancer; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Proton Collaborative Group | Conditions: Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING